Type your tag names separated by a space and hit enter

Anti-leukotrienes for asthma

Anti-leukotrienes for asthma is a topic covered in the Evidence-Based Medicine Guidelines.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central


"Anti-leukotrienes for Asthma." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/450263/all/Anti_leukotrienes_for_asthma.
Anti-leukotrienes for asthma. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/450263/all/Anti_leukotrienes_for_asthma. Accessed March 24, 2019.
Anti-leukotrienes for asthma. (2019). In Evidence-Based Medicine Guidelines. Available from https://evidence.unboundmedicine.com/evidence/view/EBMG/450263/all/Anti_leukotrienes_for_asthma
Anti-leukotrienes for Asthma [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2019 March 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/450263/all/Anti_leukotrienes_for_asthma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Anti-leukotrienes for asthma ID - 450263 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450263/all/Anti_leukotrienes_for_asthma PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -